Literature DB >> 21731585

Isolated imprinting mutation of the DLK1/GTL2 locus associated with a clinical presentation of maternal uniparental disomy of chromosome 14.

I K Temple1, V Shrubb, M Lever, H Bullman, D J G Mackay.   

Abstract

The clinical phenotypes of maternal and paternal uniparental disomy of chromosome 14 (UPD14) are attributed to dysregulation of imprinted genes. A large candidate locus exists within 14q32, under the regulation of a paternally methylated intergenic differentially methylated region (IG-DMR). We present a patient with clinical features of maternal UPD14, including growth retardation, hypotonia, scoliosis, small hands and feet, and advanced puberty, who had loss of methylation of the IG-DMR with no evidence of maternal UPD14. This case provides support for the hypothesis that the maternal UPD14 phenotype is due to aberrant gene expression within the imprinted domain at 14q32.

Entities:  

Year:  2009        PMID: 21731585      PMCID: PMC3027731          DOI: 10.1136/bcr.06.2009.1997

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  14 in total

1.  Novel imprinted DLK1/GTL2 domain on human chromosome 14 contains motifs that mimic those implicated in IGF2/H19 regulation.

Authors:  A A Wylie; S K Murphy; T C Orton; R L Jirtle
Journal:  Genome Res       Date:  2000-11       Impact factor: 9.043

Review 2.  Search for imprinted regions on chromosome 14: comparison of maternal and paternal UPD cases with cases of chromosome 14 deletion.

Authors:  V R Sutton; L G Shaffer
Journal:  Am J Med Genet       Date:  2000-08-28

Review 3.  Epigenetic regulation of mammalian genomic imprinting.

Authors:  Katia Delaval; Robert Feil
Journal:  Curr Opin Genet Dev       Date:  2004-04       Impact factor: 5.578

4.  Microdeletions in the human H19 DMR result in loss of IGF2 imprinting and Beckwith-Wiedemann syndrome.

Authors:  Angela Sparago; Flavia Cerrato; Maria Vernucci; Giovanni Battista Ferrero; Margherita Cirillo Silengo; Andrea Riccio
Journal:  Nat Genet       Date:  2004-08-15       Impact factor: 38.330

Review 5.  Segmental and full paternal isodisomy for chromosome 14 in three patients: narrowing the critical region and implication for the clinical features.

Authors:  Masayo Kagami; Gen Nishimura; Torayuki Okuyama; Michiko Hayashidani; Toshio Takeuchi; Shinya Tanaka; Fumitoshi Ishino; Kenji Kurosawa; Tsutomu Ogata
Journal:  Am J Med Genet A       Date:  2005-10-01       Impact factor: 2.802

6.  Uniparental heterodisomy for chromosome 14 in a phenotypically abnormal familial balanced 13/14 Robertsonian translocation carrier.

Authors:  J C Wang; M B Passage; P H Yen; L J Shapiro; T K Mohandas
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

7.  dlk acts as a negative regulator of Notch1 activation through interactions with specific EGF-like repeats.

Authors:  Victoriano Baladrón; María José Ruiz-Hidalgo; María Luisa Nueda; María José M Díaz-Guerra; José Javier García-Ramírez; Ezio Bonvini; Elena Gubina; Jorge Laborda
Journal:  Exp Cell Res       Date:  2004-11-02       Impact factor: 3.905

8.  Maternal uniparental disomy for chromosome 14.

Authors:  I K Temple; A Cockwell; T Hassold; D Pettay; P Jacobs
Journal:  J Med Genet       Date:  1991-08       Impact factor: 6.318

Review 9.  A case of segmental paternal isodisomy of chromosome 14.

Authors:  Karen J Coveler; Sam P Yang; ReidV Sutton; Jay M Milstein; Yuan-Qing Wu; Knox-Du Bois; Linda S Beischel; John P Johnson; Lisa G Shaffer
Journal:  Hum Genet       Date:  2002-02-26       Impact factor: 4.132

10.  Mice lacking paternally expressed Pref-1/Dlk1 display growth retardation and accelerated adiposity.

Authors:  Yang Soo Moon; Cynthia M Smas; Kichoon Lee; Josep A Villena; Kee-Hong Kim; Eun Jun Yun; Hei Sook Sul
Journal:  Mol Cell Biol       Date:  2002-08       Impact factor: 4.272

View more
  1 in total

Review 1.  Genomic conflicts and sexual antagonism in human health: insights from oxytocin and testosterone.

Authors:  Mikael Mokkonen; Bernard J Crespi
Journal:  Evol Appl       Date:  2015-02-04       Impact factor: 5.183

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.